Zhansong Lin
Research Fellow
Impact of immunogenetic variation on disease outcome
The Carrington Lab studies the human leukocyte antigen (HLA) class I and class II genetic loci.
The Carrington Lab posits that, while HLA allele disease associations are often attributed to variation at positions that determine specificity for antigenic peptides, there are other mechanisms by which HLA polymorphism influences the immune response. These include HLA class I interactions with innate immune receptors such as KIR and LILR, cell surface expression levels of HLA class I and class II, and allele-specific variation in HLA dependency on tapasin, a key component of the peptide loading complex. Our studies have identified novel HLA associations in a relatively large number of different types of human disorders, including infectious diseases, cancer, autoimmunity, reproductive diseases, and transplantation outcome.
Principal Investigator
Dr. Carrington obtained her Ph.D. at Iowa State University in the Immunobiology Department. She performed her postdoctoral studies in the departments of Immunology and Microbiology at Duke University and the University of North Carolina. Prior to her current appointments at the Frederick National Laboratory for Cancer Research, the Laboratory of Integrative Cancer Immunology, National Cancer Institute, and the Ragon Institute.
Science, 359:86-90, PMID: 29302013, 2018
J. Clin. Invest., PMID: 29461980, 128:1903-1912, 2018
Science, PMID: 31048479, 364:438-439, 2019
Nat. Immunol., PMID: 31209403, 20:824-834, 2019
Nat. Immunol., PMID: 31358998, 20:1129-1137, 2019
Blood, PMID: 32483623, 136:362-369, 2020
PNAS, PMID: 33097667, 117:28232-28238, 2020
Research Fellow
Research Technician II
Research Fellow